Externally used paste for treating rheumatic and rheumatoid arthritis and its preparation method and use

A technology of osteoarthritis and external ointment, applied in the field of medicine, can solve the problems of increased psychological and economic burden for patients, painful life quality of patients, side effects of gastrointestinal tract, etc., to speed up wound healing, ensure smooth blood flow, and inhibit inflammation response effect

Inactive Publication Date: 2015-11-11
吴秉民
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine mainly focuses on symptoms and pain relief, and a few even require joint replacement, which causes great pain to patients and reduces the quality of life
The current treatment of western medicine mainly includes conservative treatment and surgical treatment. Conservative treatment of western medicine is mainly oral non-steroidal anti-inflammatory drugs, but these drugs often show very serious gastrointestinal side effects, and surgical treatment will increase the burden on patients. Psychological and financial burden

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Externally used paste for treating rheumatic and rheumatoid arthritis and its preparation method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Embodiment 1 The preparation of the external ointment for the treatment of rheumatic rheumatoid osteoarthritis of the present invention

[0040] Weigh each component according to the following weight: methyl glucose sesquistearate 0.1g, pentaerythritol distearate 0.1g, glyceryl stearate 0.1g, shea butter 0.1g, cyclopolymer di Methicone 0.1g, Dimethicone 0.1g, Cetearyl Alcohol 0.1g, Tocopheryl Acetate 0.1g, Bisabolol 0.1g, Methyl Salicylate 0.1g, EDTA Disodium 0.01g, Allantoin 0.01g, Glycerin 0.01g, Jojoba Wax PEG-120 Esters 0.01g, Sodium Hyaluronate 0.01g, Carbomer 0.01g, Hydroxyethylurea 0.01g, Trehalose 0.01g , β-glucan 0.01g, glucosamine hydrochloride 0.01g, chondroitin sulfate 0.01g, dimethyl sulfone 0.01g, caprylic / capric triglyceride 0.01g, capsaicin 0.01g, sodium acrylate / acryloyl di 0.01 g of sodium methyl taurate copolymer, 0.01 g of bis(hydroxymethyl) imidazolidinyl urea, and 0.01 g of essence were added to 1000 mL of distilled water. Sterilize each producti...

Embodiment 2

[0041] Embodiment 2 The preparation of the external ointment for the treatment of rheumatic rheumatoid osteoarthritis of the present invention

[0042] Weigh each component according to the following weight: methyl glucose sesquistearate 5.0g, pentaerythritol distearate 5.0g, glyceryl stearate 5.0g, shea butter 5.0g, cyclopolydimethyl Dimethicone 5.0g, Dimethicone 5.0g, Cetearyl Alcohol 5.0g, Tocopheryl Acetate 5.0g, Bisabolol 5.0g, Methyl Salicylate 5.0g, EDTA Di Sodium 5.0g, Allantoin 5.0g, Glycerin 5.0g, Jojoba Wax PEG-120 Esters 5.0g, Sodium Hyaluronate 5.0g, Carbomer 5.0g, Hydroxyethylurea 5.0g, Trehalose 5.0g, β-Glucan 5.0g, Glucosamine Hydrochloride 5.0g, Chondroitin Sulfate 5.0g, Dimethylsulfone 5.0g, Caprylic / Capric Triglyceride 5.0g, Capsaicin 5.0g, Sodium Acrylate / Acryloyldimethyl 5.0 g of sodium taurate copolymer, 5.0 g of bis(hydroxymethyl) imidazolidinyl urea, and 5.0 g of essence, and make up 1000 mL of distilled water. Sterilize each production utensil and re...

Embodiment 3

[0043] Embodiment 3 The preparation of the external ointment of the present invention for the treatment of rheumatism rheumatoid osteoarthritis

[0044] Weigh each component according to the following weight: 1.5 parts of methyl glucose sesquistearate, 0.8 parts of pentaerythritol distearate, 1.1 parts of glycerol stearate, 2.5 parts of shea butter, cyclopolydimethyl 2.6 parts of silicone, 1.5 parts of polydimethylsiloxane, 1.01 parts of cetearyl alcohol, 0.3 parts of tocopheryl acetate, 0.1 parts of bisabolol, 0.1 parts of methyl salicylate, EDTA di Sodium 0.03, Allantoin 0.08, Glycerin 4.0, Jojoba Wax PEG-120 Esters 0.25, Sodium Hyaluronate 0.02, Carbomer 0.08, Hydroxyethyl Urea 1.5, Trehalose 0.7, β- 1.5 parts of dextran, 0.2 parts of glucosamine hydrochloride, 0.2 parts of chondroitin sulfate, 0.2 parts of dimethyl sulfone, 4.0 parts of caprylic acid / capric triglyceride, 0.02 parts of capsaicin, sodium acrylate / acryloyl dimethyl oxalate 0.3 part of sodium sulfonate copoly...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses externally used paste for treating rheumatic and rheumatoid arthritis and its preparation method and use. The externally used paste comprises methyl glucse sesquistearate, pentaerythritol distearate, glyceryl stearate, shea butter, cyclomethicone, polydimethylsiloxane, cetearyl alcohol, tocopheryl acetate, bisabolol, methyl salicylate, disodium EDTA, allantoin, glycerinum, jojoba wax PEG-120 ester, sodium hyaluronate, carbomer, hydroxyethylurea, trehalose, beta-glucan, D-glucosamine hydrochloride, chondroitin sulfate, dimethyl sulfone, caprylic/capric triglyceride, capsaicin, a sodium acrylate/sodium acryloyldimethyl taurate copolymer, bis(hydroxymethyl)imidazolidinyl urea, essence and distilled water. The externally used paste has good treatment effects, lasting curative effects and no side effect.

Description

technical field [0001] The invention relates to an external ointment for treating rheumatoid rheumatoid osteoarthritis, a preparation method and application thereof, and belongs to the technical field of medicine. Background technique [0002] Osteoarthritis is a common chronic progressive arthritis characterized by degeneration and destruction of articular cartilage, subbone sclerosis, reactive hyperplasia of joint margins and subchondral bone, and osteophyte formation. Osteoarthritis is more common in the elderly, and epidemiological surveys show that its incidence rate is 40% among people aged 55 to 64, and the incidence rate among people over 65 years old reaches 60%. With the increase of the world's aging population, the incidence of osteoarthritis is also increasing year by year. Patients with osteoarthritis have pain, joint deformation, and severe cases lead to plastid disability, which reduces the quality of life of the elderly and brings physical and mental health p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/54A61K9/06A61P19/02A61P29/00A61K31/737
Inventor 吴秉民
Owner 吴秉民
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap